United States· US:76346-654_4b30c5df-70a3-418c-b2f4-26ab504eb0a3

Mifepristone

A mifepristone product containing mifepristone, registered in United States by Corcept Therapeutics Incorporated. The same ATC class is registered in 14 of our 19 countries.

ATC G03XB01US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mifepristoneAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Mifepristone is registered in 14 of 19 countries.

Countries holding a registration under ATC G03XB01 (mifepristone), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
8 of them publish a price we can compare per daily dose

Search mifepristone products by name

Mifepristone · ATC G03XB01

14 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mifepristone costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Mifepristone · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

CH Switzerland$53.60

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: MIFEPRISTONE
Manufacturer: Corcept Therapeutics Incorporated
Country: United States (US)
ATC code: G03XB01
ATC class: Mifepristone
Defined daily dose: 0.2 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
7634665403
280 TABLET in 1 BOTTLE (76346-654-03)
ndc11
76346-654-03

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

378 interactions on record for mifepristone.

Graded by severity as the source publishes them — 209 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check mifepristone against other medicines How interaction checks work

Mifepristone · interactions on record

378 records

209 severe
161 moderate
8 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mifepristone in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mifepristone products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Mifegyne
Belgium · Mifegyne
Bulgaria · Мифегин
Cyprus · Mifegyne
Czechia · Mifegyne
Germany · Mifegyne
Denmark · Mifegyne
Estonia · Mifegyne
Spain · Mifegyne
Finland · Mifegyne
France · Mifegyne, Miffee
United Kingdom (Northern Ireland) · Mifegyne, Mifepristone Linepharma
Greece · Mifegyne
Croatia · Mifegyne
Ireland · Mifegyne
Iceland · Mifegyne
Italy · Mifegyne
Lithuania · Mifegyne
Luxembourg · Mifegyne
Latvia · Mifegyne
Netherlands · Mifegyne
Norway · Mifegyne
Portugal · Mifegyne
Romania · Mifegyne
Sweden · Mifegyne, Mifepristone Nordic
Slovenia · Mifegyne

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/39c64225-832d-42fa-80df-696ae42fad3f
GET /v1/drugs/39c64225-832d-42fa-80df-696ae42fad3f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "300",
  "substance": "MIFEPRISTONE",
  "productndc": "76346-654",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA202107",
  "marketing_category": "NDA"
}

API reference MCP server Plans

See everything about mifepristone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console